Adicet Bio, Inc. (ACET)
NASDAQ: ACET · Real-Time Price · USD
6.64
-0.50 (-7.00%)
At close: Oct 1, 2026, 4:00 PM EDT
6.72
+0.08 (1.20%)
After-hours: Oct 1, 2026, 7:11 PM EDT
Adicet Bio Employees
Adicet Bio had 102 employees as of December 31, 2025. The number of employees decreased by 50 or -32.89% compared to the previous year.
Employees
102
Change (1Y)
-50
Growth (1Y)
-32.89%
Revenue / Employee
n/a
Profits / Employee
-$970,333
Market Cap
71.48M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 102 | -50 | -32.89% | 102 | 0 |
| Dec 31, 2024 | 152 | 9 | 6.29% | 152 | 0 |
| Dec 31, 2023 | 143 | 11 | 8.33% | 143 | 0 |
| Dec 31, 2022 | 132 | 46 | 53.49% | 132 | 0 |
| Dec 31, 2021 | 86 | 4 | 4.88% | 86 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Champions Oncology | 214 |
| Gossamer Bio | 162 |
| Alps Group | 93 |
| XBiotech | 87 |
| Connect Biopharma Holdings | 64 |
| Pliant Therapeutics | 49 |
| Spero Therapeutics | 25 |
| RenovoRx | 17 |
ACET News
- 1 day ago - Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 2 days ago - Adicet Bio price target raised to $28 from $25 at Wedbush - TheFly
- 3 days ago - Adicet Bio trading resumes - TheFly
- 3 days ago - Adicet Bio price target raised to $34 from $27 at H.C. Wainwright - TheFly
- 3 days ago - Adicet Bio trading halted, volatility trading pause - TheFly
- 3 days ago - Adicet Bio Transcript: Study update - Transcripts
- 3 days ago - Adicet Bio Press release: Study update - Filings
- 3 days ago - Adicet Bio Slides: Study update - Filings